Your browser doesn't support javascript.
loading
Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children".
Seylanova, Nina; Chernyavskaya, Anastasia; Degtyareva, Natalia; Mursalova, Aigun; Ajam, Ali; Xiao, Lin; Aktulaeva, Khazhar; Roshchin, Philipp; Bobkova, Polina; Aiyegbusi, Olalekan Lee; Anbu, Anbarasu Theodore; Apfelbacher, Christian; Asadi-Pooya, Ali Akbar; Ashkenazi-Hoffnung, Liat; Brackel, Caroline; Buonsenso, Danilo; de Groote, Wouter; Diaz, Janet V; Dona, Daniele; Dunn Galvin, Audrey; Genuneit, Jon; Goss, Helen; Hughes, Sarah E; Jones, Christina J; Kuppalli, Krutika; Malone, Laura A; McFarland, Sammie; Needham, Dale M; Nekliudov, Nikita; Nicholson, Timothy R; Oliveira, Carlos R; Schiess, Nicoline; Segal, Terry Y; Sigfrid, Louise; Thorne, Claire; Vijverberg, Susanne; Warner, John O; Were, Wilson Milton; Williamson, Paula R; Munblit, Daniel.
Afiliação
  • Seylanova N; Independent researcher, London, UK.
  • Chernyavskaya A; Authors contributed equally to the study; apart from the two joint first authors, who contributed equally, the primary study team members and the last author, authors are listed in alphabetical order.
  • Degtyareva N; Department of Paediatrics and Paediatric Rheumatology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Mursalova A; National Medical Research Center for Children's Health, Moscow, Russia.
  • Ajam A; Authors contributed equally to the study; apart from the two joint first authors, who contributed equally, the primary study team members and the last author, authors are listed in alphabetical order.
  • Xiao L; Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Aktulaeva K; University of Birmingham, Birmingham, UK.
  • Roshchin P; University of Birmingham, Birmingham, UK.
  • Bobkova P; University of Birmingham, Birmingham, UK.
  • Aiyegbusi OL; University of Birmingham, Birmingham, UK.
  • Anbu AT; University of Birmingham, Birmingham, UK.
  • Apfelbacher C; University of Birmingham, Birmingham, UK.
  • Asadi-Pooya AA; University of Birmingham, Birmingham, UK.
  • Ashkenazi-Hoffnung L; Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Brackel C; University of Magdeburg, Magdeburg, Germany.
  • Buonsenso D; Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • de Groote W; Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Diaz JV; Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Dona D; Department of Paediatric Pulmonology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Dunn Galvin A; Department of Pediatrics, Tergooi Hospital, Blaricum, The Netherlands.
  • Genuneit J; Center for Global Health Research and Studies, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Goss H; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Hughes SE; World Health Organization, Geneva, Switzerland.
  • Jones CJ; Department for Women's and Children's Health, University of Padua, Padua, Italy.
  • Kuppalli K; Department for Women's and Children's Health, University of Padua, Padua, Italy.
  • Malone LA; University of Cork, Cork, Ireland.
  • McFarland S; Pediatric Epidemiology, Department of Pediatrics, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Needham DM; Long Covid Kids Charity, Salisbury, UK.
  • Nekliudov N; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Nicholson TR; School of Psychology, University of Surrey, Guildford, UK.
  • Oliveira CR; Department for Women's and Children's Health, University of Padua, Padua, Italy.
  • Schiess N; Kennedy Krieger Institute, Baltimore, MD, USA.
  • Segal TY; Departments of Neurology and Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD, USA.
  • Sigfrid L; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Thorne C; Outcomes After Critical Illness and Surgery (OACIS) Research Group, Johns Hopkins University, Baltimore, MD, USA.
  • Vijverberg S; Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Warner JO; Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Were WM; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
  • Williamson PR; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Munblit D; Yale University School of Medicine, Department of Pediatrics, Section of Infectious Diseases, New Haven, CT, USA.
Eur Respir J ; 63(3)2024 Mar.
Article em En | MEDLINE | ID: mdl-38359962
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic substantially impacted different age groups, with children and young people not exempted. Many have experienced enduring health consequences. Presently, there is no consensus on the health outcomes to assess in children and young people with post-COVID-19 condition. Furthermore, it is unclear which measurement instruments are appropriate for use in research and clinical management of children and young people with post-COVID-19. To address these unmet needs, we conducted a consensus study, aiming to develop a core outcome set (COS) and an associated core outcome measurement set (COMS) for evaluating post-COVID-19 condition in children and young people. Our methodology comprised of two phases. In phase 1 (to create a COS), we performed an extensive literature review and categorisation of outcomes, and prioritised those outcomes in a two-round online modified Delphi process followed by a consensus meeting. In phase 2 (to create the COMS), we performed another modified Delphi consensus process to evaluate measurement instruments for previously defined core outcomes from phase 1, followed by an online consensus workshop to finalise recommendations regarding the most appropriate instruments for each core outcome. In phase 1, 214 participants from 37 countries participated, with 154 (72%) contributing to both Delphi rounds. The subsequent online consensus meeting resulted in a final COS which encompassed seven critical

outcomes:

fatigue; post-exertion symptoms; work/occupational and study changes; as well as functional changes, symptoms, and conditions relating to cardiovascular, neuro-cognitive, gastrointestinal and physical outcomes. In phase 2, 11 international experts were involved in a modified Delphi process, selecting measurement instruments for a subsequent online consensus workshop where 30 voting participants discussed and independently scored the selected instruments. As a result of this consensus process, four instruments met a priori consensus criteria for inclusion PedsQL multidimensional fatigue scale for "fatigue"; PedsQL gastrointestinal symptom scales for "gastrointestinal"; PedsQL cognitive functioning scale for "neurocognitive" and EQ-5D for "physical functioning". Despite proposing outcome measurement instruments for the remaining three core outcomes ("cardiovascular", "post-exertional malaise", "work/occupational and study changes"), a consensus was not achieved. Our international, consensus-based initiative presents a robust framework for evaluating post-COVID-19 condition in children and young people in research and clinical practice via a rigorously defined COS and associated COMS. It will aid in the uniform measurement and reporting of relevant health outcomes worldwide.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Síndrome de COVID-19 Pós-Aguda Tipo de estudo: Guideline Limite: Adolescent / Child / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Síndrome de COVID-19 Pós-Aguda Tipo de estudo: Guideline Limite: Adolescent / Child / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido